Literature DB >> 20130321

Management of combined nonunion and limb-length discrepancy after vascularised fibular grafting.

H Abdel-Ghani1, W Ebeid, H El-Barbary.   

Abstract

We describe the management of nonunion combined with limb-length discrepancy following vascularised fibular grafting for the reconstruction of long-bone defects in the lower limb after resection of a tumour in skeletally immature patients. We operated on nine patients with a mean age of 13.1 years (10.5 to 14.5) who presented with a mean limb-length discrepancy of 7 cm (4 to 9) and nonunion at one end of a vascularised fibular graft, which had been performed previously, to reconstruct a bone defect after resection of an osteosarcoma. Reconstruction was carried out using a ring fixator secured with correction by half pins of any malalignment, compression of the site of nonunion and lengthening through a metaphyseal parafocal osteotomy without bone grafting. The expected limb-length discrepancy at maturity was calculated using the arithmetic method. Solid union and the intended leg length were achieved in all the patients. Excessive scarring and the distorted anatomy from previous surgery in these patients required other procedures to be performed with minimal exposures and dissection in order to avoid further compromise to the vascularity of the graft or damage to neurovascular structures. The methods which we chose were simple and effective in addressing these complex problems.

Entities:  

Mesh:

Year:  2010        PMID: 20130321     DOI: 10.1302/0301-620X.92B2.22758

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  2 in total

1.  Stability of tibial defect reconstruction with fibular graft and unilateral external fixation: a finite element study.

Authors:  Huiqiang Chen; Ying Zhang; Hong Xia; Fei Wang; Zhibo Li; Xuxiang Chen
Journal:  Int J Clin Exp Med       Date:  2014-01-15

2.  Treatment of osteosarcoma around the knee in skeletally immature patients.

Authors:  Weitao Yao; Qiqing Cai; Jiaqiang Wang; Songtao Gao
Journal:  Oncol Lett       Date:  2017-09-06       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.